The role of CDK4/6 inhibitors in the treatment of metastatic breast cancer

Share :
Published: 17 Apr 2023
Views: 98
Rating:
Save
Dr Delia Guaqueta - Memorial Healthcare System, Miami, USA

Dr Delia Guaqueta speaks to ecancer about the role of CDK4/6 inhibitors in the treatment of metastatic breast cancer.

She discusses the data from different trials investigating CDK4/6 inhibitors in the treatment of metastatic breast cancer.

Dr Guaqueta talks about drug approvals and concludes by talking about ecancer.

She says ecancer provides a great opportunity to reach all kinds of physicians and physicians in training and provides an international platform to discuss experiences in treating cancer.
 

This programme has been supported by an unrestricted educational grant from Pfizer.